The Madison company founded by stem cell pioneer James Thomson said Friday it has forged an agreement to use cell reprogramming technologies developed by a rival Japanese scientist.
Cellular Dynamics International Inc. negotiated a non-exclusive licensing agreement to use the techniques covered by Kyoto Universityâ??s patents on some of Shinya Yamanakaâ??s groundbreaking work. This makes the company, known as CDI, the first in the world to license key patents from both stem cell leaders involving an alternative to embryonic stem cells known as iPS, or induced pluripotent stem cells, CDI said.